_id
69130e72ccc777a4e85d7dbc
Ticker
LIANY
Name
LianBio
Exchange
PINK
Address
103 Carnegie Center Drive, Princeton, NJ, United States, 08540
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.lianbio.com
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
Last Close
0.095
Volume
-
Current Price
0.0931
Change
-6.122448979591842
Last Updated
2026-01-04T16:30:59.383Z
Image
-
Ipo Date
2021-11-01T00:00:00.000Z
Market Cap
10366990
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-12-31
Revenue
-
Cost Of Revenue
347371
Gross Profit
-347000
Operating Expenses
22122000
Operating Income
-22469000
Interest Expense
-
Pretax Income
382954000
Net Income
383733000
Eps
3.5489757225433527
Dividends Per Share
-
Shares Outstanding
109126212
Income Tax Expense
-779000
EBITDA
383301000
Operating Margin
-
Total Other Income Expense Net
405423000
Cash
438584087
Short Term Investments
128790025
Receivables
39912007
Inventories
1
Total Current Assets
613466122
Property Plant Equipment
4426000
Total Assets
617963123
Payables
4017000
Short Term Debt
1946000
Long Term Debt
-
Total Liabilities
36766007
Equity
581197116
Bs_currency_symbol
-
Depreciation
347371
Change In Working Capital
-30466736
Cash From Operations
311521662
Capital Expenditures
146662
Cash From Investing
21601603
Cash From Financing
1782449
Net Change In Cash
335127348
Cf_currency_symbol
-
PE
-
PB
0.017320177996203272
ROE
66.02458777513961
ROA
62.09642383466303
FCF
311375000
Fcf Percent
-
Piotroski FScore
3
Health Score
82
Deep Value Investing Score
9.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.5
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
8
Quality Investing Score
5
Value Investing Score
10
Quarters > 0 > quarter
2023-12-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
347371
Quarters > 0 > income Statement > gross Profit
-347000
Quarters > 0 > income Statement > operating Expenses
22122000
Quarters > 0 > income Statement > operating Income
-22469000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
382954000
Quarters > 0 > income Statement > net Income
383733000
Quarters > 0 > income Statement > eps
3.5489757225433527
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
108125000
Quarters > 0 > income Statement > income Tax Expense
-779000
Quarters > 0 > income Statement > EBITDA
383301000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
405423000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
438584087
Quarters > 0 > balance Sheet > short Term Investments
128790025
Quarters > 0 > balance Sheet > receivables
39912007
Quarters > 0 > balance Sheet > inventories
1
Quarters > 0 > balance Sheet > total Current Assets
613466122
Quarters > 0 > balance Sheet > property Plant Equipment
4426000
Quarters > 0 > balance Sheet > total Assets
617963123
Quarters > 0 > balance Sheet > payables
4017000
Quarters > 0 > balance Sheet > short Term Debt
1946000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
36766007
Quarters > 0 > balance Sheet > equity
581197116
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
383733260
Quarters > 0 > cash Flow > depreciation
347371
Quarters > 0 > cash Flow > change In Working Capital
-30466736
Quarters > 0 > cash Flow > cash From Operations
311521662
Quarters > 0 > cash Flow > capital Expenditures
146662
Quarters > 0 > cash Flow > cash From Investing
21601603
Quarters > 0 > cash Flow > cash From Financing
1782449
Quarters > 0 > cash Flow > net Change In Cash
335127348
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
3.5489757225433527
Quarters > 0 > ratios > PB
0.017320177996203272
Quarters > 0 > ratios > ROE
66.02458777513961
Quarters > 0 > ratios > ROA
62.09642383466303
Quarters > 0 > ratios > FCF
311375000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
82
Quarters > 1 > quarter
2023-09-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
300018
Quarters > 1 > income Statement > gross Profit
-300000
Quarters > 1 > income Statement > operating Expenses
26003000
Quarters > 1 > income Statement > operating Income
-26301000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-23453000
Quarters > 1 > income Statement > net Income
-24039000
Quarters > 1 > income Statement > eps
-0.22431136160047777
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
107168000
Quarters > 1 > income Statement > income Tax Expense
586036
Quarters > 1 > income Statement > EBITDA
-23153982
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2848000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
103456739
Quarters > 1 > balance Sheet > short Term Investments
148764625
Quarters > 1 > balance Sheet > receivables
1810995
Quarters > 1 > balance Sheet > inventories
1
Quarters > 1 > balance Sheet > total Current Assets
257804351
Quarters > 1 > balance Sheet > property Plant Equipment
5007987
Quarters > 1 > balance Sheet > total Assets
262901338
Quarters > 1 > balance Sheet > payables
6229000
Quarters > 1 > balance Sheet > short Term Debt
1893000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
26789932
Quarters > 1 > balance Sheet > equity
202337491
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-24040511
Quarters > 1 > cash Flow > depreciation
300018
Quarters > 1 > cash Flow > change In Working Capital
4249732
Quarters > 1 > cash Flow > cash From Operations
-15860798
Quarters > 1 > cash Flow > capital Expenditures
159431
Quarters > 1 > cash Flow > cash From Investing
15571431
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-599047
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.22431136160047777
Quarters > 1 > ratios > PB
0.04931039102387605
Quarters > 1 > ratios > ROE
-11.880645490459305
Quarters > 1 > ratios > ROA
-9.143734369278867
Quarters > 1 > ratios > FCF
-16020229
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2023-06-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
296781
Quarters > 2 > income Statement > gross Profit
-297000
Quarters > 2 > income Statement > operating Expenses
24479000
Quarters > 2 > income Statement > operating Income
-25044000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-21421000
Quarters > 2 > income Statement > net Income
-21621000
Quarters > 2 > income Statement > eps
-0.20175618677914225
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
107164000
Quarters > 2 > income Statement > income Tax Expense
200000
Quarters > 2 > income Statement > EBITDA
-24710000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
3623000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
104055786
Quarters > 2 > balance Sheet > short Term Investments
163203960
Quarters > 2 > balance Sheet > receivables
1353958
Quarters > 2 > balance Sheet > inventories
1
Quarters > 2 > balance Sheet > total Current Assets
273089567
Quarters > 2 > balance Sheet > property Plant Equipment
5610826
Quarters > 2 > balance Sheet > total Assets
278789391
Quarters > 2 > balance Sheet > payables
1908000
Quarters > 2 > balance Sheet > short Term Debt
1859000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
23292280
Quarters > 2 > balance Sheet > equity
221724153
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-21389072
Quarters > 2 > cash Flow > depreciation
296781
Quarters > 2 > cash Flow > change In Working Capital
-160727
Quarters > 2 > cash Flow > cash From Operations
-19127595
Quarters > 2 > cash Flow > capital Expenditures
49617
Quarters > 2 > cash Flow > cash From Investing
21670784
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
1722645
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.20175618677914225
Quarters > 2 > ratios > PB
0.0449972105655084
Quarters > 2 > ratios > ROE
-9.751305713635988
Quarters > 2 > ratios > ROA
-7.755316628960246
Quarters > 2 > ratios > FCF
-19177212
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2023-03-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
323366
Quarters > 3 > income Statement > gross Profit
-323000
Quarters > 3 > income Statement > operating Expenses
25595000
Quarters > 3 > income Statement > operating Income
-25969000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-23607000
Quarters > 3 > income Statement > net Income
-24045000
Quarters > 3 > income Statement > eps
-0.22437991078927233
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
107162000
Quarters > 3 > income Statement > income Tax Expense
437144
Quarters > 3 > income Statement > EBITDA
-23237634
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
2362000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
102333141
Quarters > 3 > balance Sheet > short Term Investments
184201454
Quarters > 3 > balance Sheet > receivables
3951966
Quarters > 3 > balance Sheet > inventories
1
Quarters > 3 > balance Sheet > total Current Assets
296047516
Quarters > 3 > balance Sheet > property Plant Equipment
6439945
Quarters > 3 > balance Sheet > total Assets
302580461
Quarters > 3 > balance Sheet > payables
5431000
Quarters > 3 > balance Sheet > short Term Debt
1906000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
28155763
Quarters > 3 > balance Sheet > equity
240650981
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-23998017
Quarters > 3 > cash Flow > depreciation
323366
Quarters > 3 > cash Flow > change In Working Capital
3052024
Quarters > 3 > cash Flow > cash From Operations
-17597548
Quarters > 3 > cash Flow > capital Expenditures
18962
Quarters > 3 > cash Flow > cash From Investing
40464779
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
23111979
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.22437991078927233
Quarters > 3 > ratios > PB
0.0414574757125133
Quarters > 3 > ratios > ROE
-9.991648444599525
Quarters > 3 > ratios > ROA
-7.946646627655181
Quarters > 3 > ratios > FCF
-17616510
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-09-30
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
801401
Annuals > 0 > income Statement > gross Profit
-801401
Annuals > 0 > income Statement > operating Expenses
38057079
Annuals > 0 > income Statement > operating Income
-38858480
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
2454230
Annuals > 0 > income Statement > net Income
2476241
Annuals > 0 > income Statement > eps
0.022780815941368698
Annuals > 0 > income Statement > dividends Per Share
-550697079
Annuals > 0 > income Statement > shares Outstanding
108698521
Annuals > 0 > income Statement > income Tax Expense
-22011
Annuals > 0 > income Statement > EBITDA
3255635
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
41312711
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
51701857
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10137972
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
63724824
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
63724824
Annuals > 0 > balance Sheet > payables
154999
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
858997
Annuals > 0 > balance Sheet > equity
62865827
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
2476241
Annuals > 0 > cash Flow > depreciation
801401
Annuals > 0 > cash Flow > change In Working Capital
469235
Annuals > 0 > cash Flow > cash From Operations
3746878
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
128854598
Annuals > 0 > cash Flow > cash From Financing
-550697079
Annuals > 0 > cash Flow > net Change In Cash
-386882230
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
0.022780815941368698
Annuals > 0 > ratios > PB
0.16426029828574434
Annuals > 0 > ratios > ROE
3.9389301281282756
Annuals > 0 > ratios > ROA
3.8858341923392365
Annuals > 0 > ratios > FCF
3746878
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
65
Annuals > 1 > quarter
2023-09-30
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
1327000
Annuals > 1 > income Statement > gross Profit
-1327000
Annuals > 1 > income Statement > operating Expenses
98217000
Annuals > 1 > income Statement > operating Income
-99543000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
311587000
Annuals > 1 > income Statement > net Income
311137000
Annuals > 1 > income Statement > eps
2.8718041018257
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
108342000
Annuals > 1 > income Statement > income Tax Expense
449608
Annuals > 1 > income Statement > EBITDA
312914000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
411130000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
438584087
Annuals > 1 > balance Sheet > short Term Investments
128790025
Annuals > 1 > balance Sheet > receivables
39912007
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
613466122
Annuals > 1 > balance Sheet > property Plant Equipment
4426000
Annuals > 1 > balance Sheet > total Assets
617963123
Annuals > 1 > balance Sheet > payables
4017000
Annuals > 1 > balance Sheet > short Term Debt
1946000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
36766007
Annuals > 1 > balance Sheet > equity
581197116
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
311137303
Annuals > 1 > cash Flow > depreciation
1326845
Annuals > 1 > cash Flow > change In Working Capital
-23325706
Annuals > 1 > cash Flow > cash From Operations
258935719
Annuals > 1 > cash Flow > capital Expenditures
374674
Annuals > 1 > cash Flow > cash From Investing
99308599
Annuals > 1 > cash Flow > cash From Financing
1782449
Annuals > 1 > cash Flow > net Change In Cash
359362925
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
2.8718041018257
Annuals > 1 > ratios > PB
0.017709120910365975
Annuals > 1 > ratios > ROE
53.53381691591188
Annuals > 1 > ratios > ROA
50.348797269574284
Annuals > 1 > ratios > FCF
258561045
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
82
Annuals > 2 > quarter
2022-09-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1005000
Annuals > 2 > income Statement > gross Profit
-1005000
Annuals > 2 > income Statement > operating Expenses
124199000
Annuals > 2 > income Statement > operating Income
-125204000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-110492000
Annuals > 2 > income Statement > net Income
-110159000
Annuals > 2 > income Statement > eps
-1.020718475209177
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
107923000
Annuals > 2 > income Statement > income Tax Expense
-333000
Annuals > 2 > income Statement > EBITDA
-109487000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
14712000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
79221162
Annuals > 2 > balance Sheet > short Term Investments
223142456
Annuals > 2 > balance Sheet > receivables
4410009
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
312773639
Annuals > 2 > balance Sheet > property Plant Equipment
7094014
Annuals > 2 > balance Sheet > total Assets
319960654
Annuals > 2 > balance Sheet > payables
1453000
Annuals > 2 > balance Sheet > short Term Debt
3702003
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
26313053
Annuals > 2 > balance Sheet > equity
259873531
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-110158952
Annuals > 2 > cash Flow > depreciation
1004804
Annuals > 2 > cash Flow > change In Working Capital
7985500
Annuals > 2 > cash Flow > cash From Operations
-99067147
Annuals > 2 > cash Flow > capital Expenditures
1842807
Annuals > 2 > cash Flow > cash From Investing
-69118774
Annuals > 2 > cash Flow > cash From Financing
1707968
Annuals > 2 > cash Flow > net Change In Cash
-148955958
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.020718475209177
Annuals > 2 > ratios > PB
0.03945259434674784
Annuals > 2 > ratios > ROE
-42.38946520490384
Annuals > 2 > ratios > ROA
-34.42892075098709
Annuals > 2 > ratios > FCF
-100909954
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-09-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
525696
Annuals > 3 > income Statement > gross Profit
-526000
Annuals > 3 > income Statement > operating Expenses
195304000
Annuals > 3 > income Statement > operating Income
-195570000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-196042000
Annuals > 3 > income Statement > net Income
-196561000
Annuals > 3 > income Statement > eps
-1.8323094849685388
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
107275000
Annuals > 3 > income Statement > income Tax Expense
518687
Annuals > 3 > income Statement > EBITDA
-195516000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-212000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
228177120
Annuals > 3 > balance Sheet > short Term Investments
155063683
Annuals > 3 > balance Sheet > receivables
7219845
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
399635453
Annuals > 3 > balance Sheet > property Plant Equipment
6644857
Annuals > 3 > balance Sheet > total Assets
426333882
Annuals > 3 > balance Sheet > payables
3231000
Annuals > 3 > balance Sheet > short Term Debt
2249975
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
39006165
Annuals > 3 > balance Sheet > equity
353554439
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-196560562
Annuals > 3 > cash Flow > depreciation
525696
Annuals > 3 > cash Flow > change In Working Capital
13803297
Annuals > 3 > cash Flow > cash From Operations
-164170626
Annuals > 3 > cash Flow > capital Expenditures
948257
Annuals > 3 > cash Flow > cash From Investing
-156143986
Annuals > 3 > cash Flow > cash From Financing
313688829
Annuals > 3 > cash Flow > net Change In Cash
-26173088
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.8323094849685388
Annuals > 3 > ratios > PB
0.028824768906380496
Annuals > 3 > ratios > ROE
-55.59568154651284
Annuals > 3 > ratios > ROA
-46.10494457487195
Annuals > 3 > ratios > FCF
-165118883
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
3.5489757225433527
Valuation > metrics > PB
0.017320177996203272
Valuation > final Score
90
Valuation > verdict
81.4% Undervalued
Profitability > metrics > ROE
66.02458777513961
Profitability > metrics > ROA
62.551620413686024
Profitability > final Score
85
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.06325910089340499
Risk > metrics > Interest Coverage
-64.7521613832853
Risk > final Score
-199
Risk > verdict
High
Liquidity > metrics > Current Ratio
102.87877276538656
Liquidity > metrics > Quick Ratio
102.87877259768572
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-292
Prev Risks > 1
30
Prev Risks > 2
-221
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-23T19:04:16.532Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.22
Earnings History > 3 > eps Estimate
-0.09
Earnings History > 3 > eps Difference
-0.13
Earnings History > 3 > surprise Percent
-144.4444
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-12-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-0.09
Earnings History > 4 > eps Difference
0.09
Earnings History > 4 > surprise Percent
100
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
-0.09
Earnings History > 5 > eps Difference
0.09
Earnings History > 5 > surprise Percent
100
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
-0.09
Earnings History > 6 > eps Difference
0.09
Earnings History > 6 > surprise Percent
100
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-25
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
3.549
Earnings History > 7 > eps Estimate
-0.19
Earnings History > 7 > eps Difference
3.739
Earnings History > 7 > surprise Percent
1967.8947
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.22
Earnings History > 8 > eps Estimate
-0.22
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2
Earnings History > 9 > eps Estimate
-0.29
Earnings History > 9 > eps Difference
0.09
Earnings History > 9 > surprise Percent
31.0345
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.22
Earnings History > 10 > eps Estimate
-0.29
Earnings History > 10 > eps Difference
0.07
Earnings History > 10 > surprise Percent
24.1379
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-27
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.17
Earnings History > 11 > eps Estimate
-0.17
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-11
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.2006
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.3908
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.2588
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-12-10
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.1212
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of LianBio
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-12-31)
(Last Updated 2023-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.